60 Degrees Pharmaceuticals I
13F holders, Q2 2024 (June 30)10holders +2
5new positions
3sold out
$0.25avg. 13F price*
At the end of Q2 2024, 10 institutions reported holding 60 Degrees Pharmaceuticals I in their 13F filings, up 2 from Q1 2024. 5 opened new positions and 3 sold out. The largest holders were Central Bank & Trust Co. ($42K), Virtu Financial LLC ($11K) and Geode Capital Management, LLC ($10K).
- Company
- 60 Degrees Pharmaceuticals I
- CUSIP
- 83006G104
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $28K |
| Exits | 3 | $29K |
All 13F filers, Q1 2024 → Q2 2024: 111,497 shares bought and 235,856 shares sold, net −124,359 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Central Bank & Trust Co. | 0.01% | Reduce -37.7% | 167,000 | $42K |
| Virtu Financial LLC | 0.00% | Reduce -24.1% | 45,140 | $11K |
| Geode Capital Management, LLC | 0.00% | New | 38,000 | $10K |
| UBS Group AG | 0.00% | New | 34,479 | $9K |
| HRT Financial LP | 0.00% | New | 28,788 | $7K |
| Two Sigma Securities, LLC | 0.00% | Reduce -28.9% | 17,196 | $4K |
| Susquehanna International Group, LLP | 0.00% | Reduce -1.8% | 13,303 | $3K |
| Raymond James & Associates | 0.00% | New | 10,000 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2.5% | 7,095 | $2K |
| Bank of America Corp. | 0.00% | New | 56 | $14 |
"% of holder's portfolio" is 60 DEGREES PHARMACEUTICALS I's weight in each manager's 13F, not the share of 60 Degrees Pharmaceuticals I the manager owns.